Copper induced oxidation of serotonin: analysis of products and toxicity.
Serotonin is a major neurotransmitter that controls many functions, ranging from mood and behaviour through to sleep and motor functions. The non-enzymatic oxidation of serotonin is of significant importance as some oxidation products are considered to be neurotoxic. An interaction between copper and serotonin has been suggested by symptoms observed in a number of neurodegenerative diseases such as Wilson's and Prion diseases. Using PC12 cells as a model of neuronal cells, we show that the interaction between copper and serotonin is toxic to undifferentiated cells. The toxicity is largely due to reactive oxygen species as cell death is significantly reduced in the presence of the antioxidant mannitol. Differentiation of the PC12 cells also confers resistance to the oxidative process. In vitro oxidation of serotonin by copper results in the eventual formation of a coloured pigment, thought to be a melanin-like polymeric species. Using spectroscopic methods we provide evidence for the formation of a single intermediate product. This dimeric intermediate was identified and characterized as 5,5'-dihydroxy-4,4'-bitryptamine. These results indicate that copper structurally alters serotonin and this process may play a role in copper related neurodegenerative diseases.
Centre for Metals in Biology, and School of Molecular and Microbial Sciences, The University of Queensland, St Lucia, Queensland, Australia. uqcjone3@uq.edu.au
Christopher E
CE
Jones
Clare K
CK
Underwood
Elizabeth J
EJ
Coulson
Paul J
PJ
Taylor
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003300:Copper / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D018696:Neuroprotective Agents / Q000494:pharmacology; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects*; D016716:PC12 Cells; D051381:Rats; D012701:Serotonin / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D013053:Spectrophotometry / Q000145:classification / Q000379:methods; D014131:Trace Elements / Q000494:pharmacology*; D014363:Tryptamines / Q000494:pharmacology
D018696:Neuroprotective Agents; D014131:Trace Elements; D014363:Tryptamines; C076856:5,5'-dihydroxy-4,4'-bitryptamine; D012701:Serotonin; D003300:Copper